IL101660A - Pharmaceutical preparation for the treatment of the immune system - Google Patents

Pharmaceutical preparation for the treatment of the immune system

Info

Publication number
IL101660A
IL101660A IL10166092A IL10166092A IL101660A IL 101660 A IL101660 A IL 101660A IL 10166092 A IL10166092 A IL 10166092A IL 10166092 A IL10166092 A IL 10166092A IL 101660 A IL101660 A IL 101660A
Authority
IL
Israel
Prior art keywords
treatment
autoimmune diseases
pharmaceutical composition
formula
compound
Prior art date
Application number
IL10166092A
Other languages
English (en)
Hebrew (he)
Original Assignee
Angelini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Ricerche Spa filed Critical Angelini Ricerche Spa
Publication of IL101660A publication Critical patent/IL101660A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL10166092A 1991-04-22 1992-04-21 Pharmaceutical preparation for the treatment of the immune system IL101660A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911101A IT1253703B (it) 1991-04-22 1991-04-22 Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie

Publications (1)

Publication Number Publication Date
IL101660A true IL101660A (en) 1996-08-04

Family

ID=11359721

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10166092A IL101660A (en) 1991-04-22 1992-04-21 Pharmaceutical preparation for the treatment of the immune system

Country Status (16)

Country Link
US (1) US5278183A (xx)
EP (1) EP0510748B1 (xx)
JP (1) JP3056879B2 (xx)
KR (1) KR100210199B1 (xx)
AT (1) ATE135573T1 (xx)
AU (1) AU657524B2 (xx)
BG (1) BG61366B2 (xx)
CA (1) CA2066304C (xx)
CZ (1) CZ280613B6 (xx)
DE (1) DE69209128T2 (xx)
DK (1) DK0510748T3 (xx)
IL (1) IL101660A (xx)
IT (1) IT1253703B (xx)
NZ (1) NZ242392A (xx)
SK (1) SK278546B6 (xx)
ZA (1) ZA922740B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723315B1 (fr) 1994-08-02 1996-10-25 Cird Galderma Procede et composition pour stimuler la differenciation des cellules preadipocytaires et traitements therapeutiques associes
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
IT1293795B1 (it) 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
WO2003035005A2 (en) * 2001-10-26 2003-05-01 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
WO2009109616A2 (en) 2008-03-07 2009-09-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
GEP20135913B (en) 2008-03-07 2013-08-26 Acraf 1-benzyl-3-hydroxymethylindazole derivatives and use thereat treatment of diseases based on mcp-1 and cx3cr1 expression
KR101599867B1 (ko) * 2008-03-07 2016-03-04 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 신규한 1-벤질-3-하이드록시메틸인다졸 유도체들 및 ｍｃｐ-1, ｃｘ3ｃｒ1 및 ｐ40의 발현을 기초로 한 질환들의 치료에서 이의 용도
KR101736301B1 (ko) 2009-08-03 2017-05-29 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 1-벤질-3-하이드록시메틸-1ｈ-인다졸 및 이의 유도체 및 필요한 마그네슘 중간체들의 제조 방법
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
US11753382B2 (en) 2019-06-25 2023-09-12 Translatum Medicus Inc. Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194564B (it) * 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
EP0191520B1 (en) * 1985-02-12 1989-06-21 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (1-phenylmethyl-5-hydroxy-1h-indazol-3-yl)-oxyacetic acid and salts thereof for use as a medicament, and pharmaceutical compositions containing them
IT1230441B (it) * 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo

Also Published As

Publication number Publication date
US5278183A (en) 1994-01-11
IT1253703B (it) 1995-08-23
JPH0640915A (ja) 1994-02-15
CA2066304A1 (en) 1992-10-23
KR920019350A (ko) 1992-11-19
DE69209128D1 (de) 1996-04-25
BG61366B2 (bg) 1997-06-30
CA2066304C (en) 2005-06-21
AU1488392A (en) 1992-10-29
DE69209128T2 (de) 1996-11-28
CZ280613B6 (cs) 1996-03-13
DK0510748T3 (da) 1996-07-22
EP0510748B1 (en) 1996-03-20
ZA922740B (en) 1992-12-30
NZ242392A (en) 1997-06-24
EP0510748A1 (en) 1992-10-28
ATE135573T1 (de) 1996-04-15
AU657524B2 (en) 1995-03-16
CS122792A3 (en) 1992-11-18
JP3056879B2 (ja) 2000-06-26
ITMI911101A0 (it) 1991-04-22
SK278546B6 (en) 1997-09-10
KR100210199B1 (ko) 1999-07-15
ITMI911101A1 (it) 1992-10-22

Similar Documents

Publication Publication Date Title
US5278183A (en) Method for the treatment of autoimmune diseases
US6509348B1 (en) Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
KR100464693B1 (ko) 5-메틸이소옥사졸-4-카복실산-(4-트리플루오로메틸)-아닐리드와n-(4-트리플루오로메틸페닐)-2-시아노-3-하이드록시크로톤산아미드와의배합물을함유하는제제
IE61232B1 (en) Medicaments to combat chronic graft-versus-host diseases and to combat autoimmune diseases, in particular systemic lupus erythematosus
CA2440744C (en) Il-12 expression controlling agent
US5344829A (en) Use of OB-101 to treat inflammation
US5198454A (en) Use of OB-104 to treat ocular inflammation
US4241086A (en) Method for treating rheumatism
WO1996008242A2 (en) Clotrimazole metabolites in the treatment of sickle cell disease
KR19990067237A (ko) 자기면역질환 치료용 제약학적 조성물
Connolly et al. Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs
PT90249B (pt) Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t
Leckie et al. Stevens–Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis
AU748608B2 (en) MTP inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
Shen Non-steroidal anti-inflammatory agents
Gervais et al. The effect of the non-steroidal anti-inflammatory drug etodolac on macrophage migration in vitro and in vivo
US4880803A (en) Method of inducing immunostimulating activity
RU2160102C2 (ru) Применение бензидамина для лечения патологических состояний, вызванных фно
Dickerson et al. Pentobarbital improves nitrogen retention in sepsis
Bjerkhoel et al. Cyclosporin Treatment of a Patient with Severe Systemic Juvenile Rheumatoid Arthritis: Introduction
HU219406B (hu) Eljárás autoimmun betegségek kezelésére alkalmas, benzil-indazol-származékokat tartalmazó gyógyszerkészítmények előállítására
US3798322A (en) 6 or 7-substituted 4 or 8-(amino-1-methyl-butylamino)quinolines as hypolipidemic agents
JPH0244454B2 (ja) Menekyokuseibutsushitsujokyozai
Ferry Jr et al. The non‐linear pharmacokinetics of prednisone and prednisolone
Florez, D Sanchez-Aguilar, J Toribio Treatment of generalized bullous pemphigoid with erythromycin and nicotinamide

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired